{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:41:19Z","timestamp":1780468879122,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.intimp.2020.107162","type":"journal-article","created":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T01:48:54Z","timestamp":1604713734000},"page":"107162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"PA","title":["Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma"],"prefix":"10.1016","volume":"89","author":[{"given":"Baohui","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyi","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianze","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.107162_b0005","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1586\/era.10.170","article-title":"A new understanding in the epidemiology of melanoma","volume":"10","author":"Erdei","year":"2010","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.intimp.2020.107162_b0010","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/jid.2008.423","article-title":"Increasing Burden of Melanoma","volume":"129","author":"Linos","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2020.107162_b0015","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2020.107162_b0020","first-page":"7","article-title":"Cancer statistics, 2018: Cancer Statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA: A Cancer J. Clinicians"},{"key":"10.1016\/j.intimp.2020.107162_b0025","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2020.107162_b0030","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved Survival with Ipilimumab in Patients with Metastatic Melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2020.107162_b0035","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1200\/JCO.2013.53.0105","article-title":"Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving Nivolumab","volume":"32","author":"Topalian","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2020.107162_b0040","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/1078-0432.CCR-17-2267","article-title":"Primary and acquired resistance to immune checkpoint inhibitors in metastatic melanoma","volume":"24","author":"Gide","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2020.107162_b0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2020.107162_b0050","first-page":"1","article-title":"Association of combined PD-L1 expression and tumour-infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma","author":"Bence","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.intimp.2020.107162_b0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2020.107162_b0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00262-013-1508-5","article-title":"Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab","volume":"63","author":"Meyer","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2020.107162_b0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3747\/co.19.945","article-title":"Major histocompatibility complex class i and tumour immuno-evasion: How to fool T cells and natural killer cells at one time","volume":"19","author":"Fruci","year":"2012","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.intimp.2020.107162_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02286-z","article-title":"A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma","volume":"18","author":"Guo","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2020.107162_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2019.01390","article-title":"Development of an Immune-Related Prognostic Signature in Breast Cancer","volume":"10","author":"Xie","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.intimp.2020.107162_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-1002-1","article-title":"Classification of triple-negative breast cancers based on Immunogenomic profiling","volume":"37","author":"He","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2020.107162_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.intimp.2020.107162_b0090","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2020.107162_b0095","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2020.107162_b0100","doi-asserted-by":"crossref","unstructured":"S. Molecules, J. Lamb, E.D. Crawford, D. Peck, J.W. Modell, I.C. Blat, M.J. Wrobel, J. Lerner, J. Brunet, A. Subramanian, K.N. Ross, M. Reich, H. Hieronymus, G. Wei, S.A. Armstrong, S.J. Haggarty, P.A. Clemons, R. Wei, S.A. Carr, E.S. Lander, T.R. Golub, The Connectivity Map\u00a0: Using, 313 (2006) 1929\u20131935.","DOI":"10.1126\/science.1132939"},{"key":"10.1016\/j.intimp.2020.107162_b0105","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12026-014-8516-1","article-title":"ImmPort: disseminating data to the public for the future of immunology","volume":"58","author":"Bhattacharya","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.intimp.2020.107162_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for Cox\u2019s proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.intimp.2020.107162_b0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","article-title":"Survival Model Predictive Accuracy and ROC Curves","volume":"61","author":"Heagerty","year":"2005","journal-title":"Biometrics"},{"key":"10.1016\/j.intimp.2020.107162_b0120","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2020.107162_b0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2020.107162_b0130","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How To Build and Interpret a Nomogram for Cancer Prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2020.107162_b0135","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1158\/0008-5472.CAN-17-0327","article-title":"Cistrome Cancer: A Web Resource for Integrative Gene Regulation Modeling in Cancer","volume":"77","author":"Mei","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2020.107162_b0140","doi-asserted-by":"crossref","unstructured":"A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, J.P. Mesirov, Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. U. S. A. (2005). https:\/\/doi.org\/10.1073\/pnas.0506580102.","DOI":"10.1073\/pnas.0506580102"},{"key":"10.1016\/j.intimp.2020.107162_b0145","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.intimp.2020.107162_b0150","article-title":"EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun"},{"key":"10.1016\/j.intimp.2020.107162_b0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.intimp.2020.107162_b0160","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2020.107162_b0165","doi-asserted-by":"crossref","unstructured":"J.T. Leek, J.D. Storey, Capturing heterogeneity in gene expression studies by surrogate variable analysis, PLoS Genet. 3 (2007) 1724\u20131735. https:\/\/doi.org\/10.1371\/journal.pgen.0030161.","DOI":"10.1371\/journal.pgen.0030161"},{"key":"10.1016\/j.intimp.2020.107162_b0170","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1253735","article-title":"The melanoma revolution: From UV carcinogenesis to a new era in therapeutics","volume":"346","author":"Lo","year":"2014","journal-title":"Science (80-.)"},{"key":"10.1016\/j.intimp.2020.107162_b0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","article-title":"Tumor microenvironment: Sanctuary of the devil","volume":"368","author":"Hui","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2020.107162_b0180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.15430\/JCP.2015.20.2.106","article-title":"Esculetin, a Coumarin Derivative, Exhibits Anti-proliferative and Pro-apoptotic Activity in G361 Human Malignant Melanoma","volume":"20","author":"Jeon","year":"2015","journal-title":"J Cancer Prev."},{"key":"10.1016\/j.intimp.2020.107162_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2017.10.021","article-title":"Repair of UV-Induced DNA Damage Independent of Nucleotide Excision Repair Is Masked by MUTYH","volume":"68","author":"Mazouzi","year":"2017","journal-title":"Mol. Cell."},{"key":"10.1016\/j.intimp.2020.107162_b0190","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/bjc.2012.580","article-title":"In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen","volume":"108","author":"Kretschy","year":"2013","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.intimp.2020.107162_b0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cbi.2015.08.014","article-title":"Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways","volume":"242","author":"Kim","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2020.107162_b0200","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bcp.2009.12.021","article-title":"Identification of known drugs that act as inhibitors of NF-\u03baB signaling and their mechanism of action","volume":"79","author":"Miller","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107162_b0205","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.bcp.2012.07.024","article-title":"PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells","volume":"84","author":"W\u0119sierska-G\u0105dek","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107162_b0210","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.bcp.2009.12.023","article-title":"Increased cytotoxicity of an unusual DNA topoisomerase II inhibitor compound C-1305 toward HeLa cells with downregulated PARP-1 activity results from re-activation of the p53 pathway and modulation of mitotic checkpoints","volume":"79","author":"Sabisz","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107162_b0215","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00280-014-2386-z","article-title":"High-dose vitamin B1 reduces proliferation in cancer cell lines analogous to dichloroacetate","volume":"73","author":"Hanberry","year":"2014","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.intimp.2020.107162_b0220","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.csbj.2020.04.014","article-title":"The science of puromycin: From studies of ribosome function to applications in biotechnology","volume":"18","author":"Aviner","year":"2020","journal-title":"Comput. Struct. Biotechnol. J"},{"key":"10.1016\/j.intimp.2020.107162_b0225","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2230.2008.02706.x","article-title":"Subcorneal pustular dermatosis: 50 Years on","volume":"33","author":"Cheng","year":"2008","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.intimp.2020.107162_b0230","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.onc.1209807","article-title":"IFITM1 plays an essential role in the antiproliferative action of interferon-\u03b3","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2020.107162_b0235","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.leukres.2004.07.007","article-title":"Expression of IFITM1 in chronic myeloid leukemia patients","volume":"29","author":"Akyerli","year":"2005","journal-title":"Leuk. Res."},{"key":"10.1016\/j.intimp.2020.107162_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers11122031","article-title":"Aberrant DNA methylation predicts melanoma-specific survival in patients with acral melanoma","volume":"11","author":"Pradhan","year":"2019","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.intimp.2020.107162_b0245","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI117788","article-title":"Monocyte chemotactic protein-1 (MCP-1),-2, and-3 are chemotactic for human T lymphocytes. Rapid Publication Monocyte Chemotactic Protein-1 (MCP-1),-2, and-3 Are Chemotactic for Human T Lymphocytes","volume":"95","author":"Taub","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2020.107162_b0250","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2011.04.024","article-title":"Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2\/CCL8 induction","volume":"308","author":"Hiwatashi","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2020.107162_b0255","doi-asserted-by":"crossref","first-page":"29111","DOI":"10.18632\/oncotarget.5059","article-title":"The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma","volume":"6","author":"Barbai","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2020.107162_b0260","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1158\/0008-5472.CAN-15-2668","article-title":"BAFF and APRIL from Activin A-Treated Dendritic Cells Upregulate the Antitumor Efficacy of Dendritic Cells In Vivo","volume":"76","author":"Shurin","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2020.107162_b0265","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4161\/rna.7.2.11344","article-title":"Diverse functions for DNA and RNA editing in the immune system","volume":"7","author":"Hamilton","year":"2010","journal-title":"RNA Biol."},{"key":"10.1016\/j.intimp.2020.107162_b0270","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1158\/1078-0432.CCR-15-2910","article-title":"APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma","volume":"22","author":"Leonard","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2020.107162_b0275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1074-7613(02)00333-3","article-title":"The Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural Killing","volume":"17","author":"Jamieson","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2020.107162_b0280","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/CMR.0000000000000164","article-title":"Tumor-infiltrating lymphocytes predict cutaneous melanoma survival","volume":"25","author":"Fortes","year":"2015","journal-title":"Melanoma Res."},{"key":"10.1016\/j.intimp.2020.107162_b0285","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science (80-.)"},{"key":"10.1016\/j.intimp.2020.107162_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0768-9","article-title":"The role of PD-L1 expression as a predictive biomarker: An analysis of all US food and drug administration (FDA) approvals of immune checkpoint inhibitors","volume":"7","author":"Davis","year":"2019","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.intimp.2020.107162_b0295","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","article-title":"CD4+ T cell help in cancer immunology and immunotherapy","volume":"18","author":"Borst","year":"2018","journal-title":"Nat Rev Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:24:34Z","timestamp":1761585874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920336298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":59,"alternative-id":["S1567576920336298"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107162","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107162"}}